Article · 4 May 2026
ArticlePublished 26 Nov 2024
Nanostructured Lipid Carriers with Dual Targeting for Treatment of Ovarian Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nanostructured lipid carriers are lipid-based nanoparticles that consist of a solid-lipid matrix and a liquid lipid component, by enhancing drugs solubility and stability it improves bioavailability and efficacy. Nanostructured lipid carriers have the skill to act as carriers loaded with various drugs, including hydrophilic and hydrophobic molecules and can be functionalized with targeting ligands or imaging agents for the purpose of targeted drug delivery and imaging. Ovarian cancer, which begins in the ovaries, is one of the most lethal forms of gynecological cancer, it also shows a very less survival rate in women due to its asymptomatic nature, late diagnosis and high recurrence rate. Different genetic variations and pathways such as tumor protein p53 mutation in high-grade serous tumors, Kirsten rat sarcoma viral oncogene homolog mutation in mucinous tumors and clear cells are used to distinguish between various types of this disease. The term “Dual targeting” describes the therapeutic strategy in which two separate molecules or pathways are targeted at once to amplify the therapeutic effect, it can be useful in overcoming drug resistance as it concurrently targets two independent pathways and lowers the risk that cancer cells will develop resistance to individual therapies. This article reviews the uses of nanostructured lipid carriers used for the treatment of ovarian cancer.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S. Ray”
- BylineArticles whose byline prints “A. N. Singh”
- BylineArticles whose byline prints “Sabira Shafat”
- BylineArticles whose byline prints “D. S. Baghel”
- BylineArticles whose byline prints “B. Kumar”
- BylineArticles whose byline prints “N. K. Panday”
- BylineArticles whose byline prints “S. Singh”
- BylineArticles whose byline prints “R. C. Rompicherla”